140 studies found for:    Open Studies | niaid
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | niaid
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Interferon Responses in Eczema Herpeticum (ADEH)
Conditions: Atopic Dermatitis;   Eczema Herpeticum;   Herpes Simplex Infections;   Eczema Vaccinatum
Intervention:
2 Not yet recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
3 Unknown  A Study of HIV-infected Subjects Initiating Anti-HIV Drugs for the First Time
Condition: HIV Infections
Intervention:
4 Unknown  Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care
Condition: HIV Infections
Interventions: Other: Provider Computer Alerts;   Other: Enhanced Provider Computer Alerts
5 Recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
6 Recruiting Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
7 Recruiting High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
Conditions: Cryptococcal Meningitis;   HIV Infections
Interventions: Drug: Fluconazole;   Drug: Amphotericin B
8 Recruiting Eosinophilic Esophagitis Databank
Conditions: Esophagitis;   Eosinophilic Esophagitis
Intervention:
9 Recruiting Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Condition: Asthma
Interventions: Biological: Omalizumab;   Drug: Fluticasone;   Biological: Placebo omalizumab;   Biological: Placebo fluticasone
10 Not yet recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
11 Recruiting Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines
Condition: Influenza, Human
Interventions: Biological: A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca);   Biological: A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca);   Biological: 2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®);   Biological: Vaccine placebo (Leibovitz-15 [L-15]);   Biological: Vaccine placebo (FluMist®)
12 Recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
13 Recruiting Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Condition: Diabetes Mellitus, Type I
Interventions: Drug: Low Molecular Weight Sulfated Dextran (LMW-SD);   Drug: Heparin;   Drug: CellCept® (Mycophenolate mofetil) OR Rapamune® (Sirolimus);   Drug: Prograf® (Tacrolimus) OR Cyclosporine;   Drug: Thymoglobulin® (Anti-thymocyte Globulin) - at first transplant;   Drug: Simulect® (Basiliximab) - at 2nd or 3rd transplant;   Drug: Klexane® (Enoxaparinsodium);   Drug: Trombyl® or Albyl-E® (Acetylsalicylicacid- ASA);   Drug: Enbrel® (Etanercept)
14 Recruiting Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine
Condition: Metapneumovirus
Interventions: Biological: 10^6 PFU rHMPV-Pa vaccine;   Biological: 10^5 PFU rHMPV-Pa vaccine;   Biological: Placebo Vaccine
15 Recruiting Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Condition: Influenza, Human
Interventions: Drug: Oseltamivir;   Drug: Oseltamivir Placebo
16 Recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)
17 Recruiting Natural History Study of SCID Disorders
Conditions: SCID;   Leaky SCID;   Omenn Syndrome;   Reticular Dysgenesis;   ADA Deficiency;   XSCID
Intervention:
18 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
19 Recruiting Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
Condition: Tuberculosis
Interventions: Drug: PA-824;   Drug: Efavirenz (EFV);   Drug: Lopinavir/Ritonavir (LPV/r);   Drug: Rifampin (RIF)
20 Recruiting Research Study of ATG and Rituximab in Renal Transplantation
Condition: Acute Kidney Injury
Interventions: Drug: ATG;   Drug: Rituximab;   Drug: Tacrolimus;   Drug: Sirolimus;   Drug: MMF

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years